Nasdaq PPHM clinical

Related by string. NASDAQ PPHM clinical * NASDAQ. . nasdaq . NASDAQ : Inc. NASDAQ SCOR . NASDAQ OMX Group . Nasdaq Listing Qualifications . Apple Nasdaq AAPL / : Peregrine Pharmaceuticals NASDAQ PPHM . Inc. Nasdaq PPHM . PPHM . Nasdaq PPHM / clinicals . CLINICAL . Clinicals . Clinical : Phase III clinical trials . placebo controlled clinical trials . Phase III clinical . Phase 2b clinical * *

Related by context. Frequent words. (Click for all words.) 73 Inc. Nasdaq IMGN 70 NASDAQ CRXL 70 Crucell NV Euronext 69 Presents Positive 67 Inc Therapeutic Competitors 67 See BioWorld Today 67 PYMX 67 Nasdaq VRTX 66 Nasdaq ALTH 66 ACADIA Pharmaceuticals 66 Adherex Technologies Inc. 66 TSX AEZ 66 Novelos Therapeutics Inc. 66 VIA Pharmaceuticals 65 Advancing Drugs 65 Skymark Research Initiates Independent 65 Barrier Therapeutics Inc. 65 Completes Enrollment 65 DOR BioPharma Inc. 65 submitted Biologics License 65 NASDAQ SHPGY 65 NovaBay Pharmaceuticals Inc. 64 Genaera Corporation 64 Threshold Pharmaceuticals Inc. 64 AVANIR Pharmaceuticals 64 NASDAQ IMCL 64 AEterna Zentaris Inc. 64 MGI PHARMA INC. 64 NASDAQ ARIA 64 Metabasis Therapeutics Inc. 64 Pluristem Therapeutics Inc. 64 By SOPHIA VORAVONG 64 Inc. NASDAQ MRNA 63 Announces Presentation 63 Immunomedics Inc. 63 Inc. Nasdaq NVAX 63 EPIX Pharmaceuticals Inc. 63 BPAX 63 Actelion Ltd 63 Ardea Biosciences Inc. 63 Q3 Loss Narrows 63 EXTON Pa. BUSINESS WIRE 63 Q2 Loss Narrows 63 SciClone Pharmaceuticals 63 Webcast Annual Meeting 63 www.twitter.com otcadvisors 63 Genelabs Technologies Inc. 63 Cyclacel Pharmaceuticals Inc. 63 Two Investor Conferences 63 Q3 Loss Widens 63 Inc. NASDAQ VVUS 63 IMPAX Laboratories Inc. 62 Intellect Neurosciences Inc. 62 www.syntapharma.com 62 Dynavax Technologies Corporation 62 NovaBay Pharmaceuticals 62 Stock Downgraded 62 BY TREVOR HUGHES 62 OncoGenex Pharmaceuticals Inc. 62 By Patti Zarling 62 Group NV Pharming 62 Report companiesandmarkets.com adds 62 Adeona Pharmaceuticals Inc. 62 ALIM 62 Nasdaq REGN 62 BioSpecifics Technologies Corp. 62 Oscient Pharmaceuticals Corporation 62 ARYx Therapeutics Inc. 62 EARNINGS LOOK AHEAD 62 QLTI 62 ImmunoGen Inc. 62 ImmuneRegen BioSciences Inc. 62 Anadys Pharmaceuticals Inc. 62 NASDAQ BPAX 62 Initiates Phase 62 Inc. NASDAQ BIIB 62 DVAX 62 Palatin Technologies Inc. 62 Rexahn Pharmaceuticals Inc. 62 LEXINGTON Mass. BUSINESS WIRE 62 Sunesis Pharmaceuticals Inc. 62 Nasdaq AMGN 62 Lipid Sciences Inc. 61 Nasdaq BIIB 61 Q4 Loss Narrows 61 Marcus Gronholm BP 61 Inc. Nasdaq ARNA 61 Pivotal Phase III 61 Cardium Therapeutics Inc. 61 Nasdaq ASTM 61 Report Initiates Independent 61 Rexahn Pharmaceuticals 61 OPTR 61 LXRX 61 Healthnostics Inc. 61 Nymox Pharmaceutical Corporation 61 R sorafenib tablets 61 Q2 Loss Widens 61 MarketTelegraph.com 61 IMMU 61 IMGN

Back to home page